Inflectra Launches Rapise 9.0 with AI-Powered Self-Healing Web Tests and Enhanced Inflectra.ai Integration

Inflectra, a leading provider of software testing and quality assurance solutions, today announced the release of Rapise 9.0, introducing breakthrough AI-powered self-healing capabilities ...
Yahoo Finance

Inflectra Joins AWS ISV Workload Migration Program to Strengthen Cloud Migration Offering

WASHINGTON, Feb. 4, 2025 /PRNewswire/ -- Inflectra, a global leader in software lifecycle management solutions, announced today that it has joined the Amazon Web Services (AWS) Independent Software ...
Yahoo Finance

Inflectra.ai Redefines the Standard: Making Enterprise AI Native, Seamless, and Scalable

WASHINGTON, May 13, 2025 /PRNewswire/ -- Inflectra, a global leader in software lifecycle management and test automation solutions, today announced the general availability of Inflectra.ai, its ...
Mena FN

Inflectra Achieves AWS Government Competency, Reinforcing Commitment To Secure And Compliant Solutions For Public Sector

(MENAFN- PR Newswire) This AWS Government Competency designatio highlights Inflectra's technical expertise and proven success in delivering solutions that meet rigorous government requirements. Now, ...
Nasdaq

Inflectra's Spira Version 7.0 Enables Partners and Customers to Create Native Plugins and Make them Available to Other Users

Inflectra, a leading maker of IT software lifecycle management solutions, today announced its latest Spira platform version release. The company’s Spira Version 7.0, which includes SpiraTest, ...
Healio

All gains in infliximab biosimilar use have gone to Inflectra

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Researchers have observed a “modest uptake” in the use of biosimilars for infliximab in the past 18 ...
FierceBiotech

Hospira's Inflectra™ (infliximab) the first biosimilar monoclonal antibody to be approved in Europe

"The rigorous scientific review and approval process by the EMA and EC confirms that Inflectra has demonstrated similar quality, efficacy and safety to Remicade. For over a decade biologic medicines ...